Using Haemocoagulase Agkistrodon in Patients Undergoing Transurethral Plasmakinetic Resection of the Prostate: A Pilot, Real-World, and Propensity Score-Matched Study

OBJECTIVES: To compare the clinical outcomes of using different hemostatic agents after transurethral plasmakinetic resection of the prostate (TUPKP) in benign prostatic hyperplasia (BPH) patients. METHODS: The patients were divided into 5 groups according to the hemostatic agents used after TUPKP,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Cong, Yang, Lan, Zi, Hao, Li, Bing-Hui, Huang, Qiao, Lu, Meng-Xin, Li, Xiao-Dong, Ren, Xuan-Yi, Tao, Hua, Hu, Hankun, Zeng, Xian-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242795/
https://www.ncbi.nlm.nih.gov/pubmed/35782057
http://dx.doi.org/10.1155/2022/9200854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242795/
https://www.ncbi.nlm.nih.gov/pubmed/35782057
http://dx.doi.org/10.1155/2022/9200854

Ejemplares similares